The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: Therapeutic implications
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference61 articles.
1. The molecular biology of myeloproliferative disorders;Radich;Cancer Cell,2010
2. Biology and treatment of primary myelofibrosis;Hoffman;Hematology Am Soc Hematol Educ Program,2007
3. Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence;Lataillade;Blood,2008
4. Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera;Wernig;Cancer Cell,2008
5. Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis;Pardanani;J Clin Oncol,2011
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent researches for dual Aurora target inhibitors in antitumor field;European Journal of Medicinal Chemistry;2020-10
2. CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages;Biochemical and Biophysical Research Communications;2020-02
3. Construction of Quantitative Structure Activity Relationship (QSAR) Models to Predict Potency of Structurally Diversed Janus Kinase 2 Inhibitors;Molecules;2019-12-01
4. Reducing PRLR expression and JAK2 activity results in an increase in BDNF expression and inhibits the apoptosis of CA3 hippocampal neurons in a chronic mild stress model of depression;Brain Research;2019-12
5. Myeloid Malignancies;The American Cancer Society's Oncology in Practice;2018-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3